These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 21843565)
1. Treatment of atherogenic liver based on the pathogenesis of nonalcoholic fatty liver disease: a novel approach to reduce cardiovascular risk? Maurantonio M; Ballestri S; Odoardi MR; Lonardo A; Loria P Arch Med Res; 2011 Jul; 42(5):337-53. PubMed ID: 21843565 [TBL] [Abstract][Full Text] [Related]
2. Fatty liver: role of inflammation and fatty acid nutrition. Byrne CD Prostaglandins Leukot Essent Fatty Acids; 2010; 82(4-6):265-71. PubMed ID: 20189787 [TBL] [Abstract][Full Text] [Related]
11. From the metabolic syndrome to NAFLD or vice versa? Vanni E; Bugianesi E; Kotronen A; De Minicis S; Yki-Järvinen H; Svegliati-Baroni G Dig Liver Dis; 2010 May; 42(5):320-30. PubMed ID: 20207596 [TBL] [Abstract][Full Text] [Related]
12. Cytokines in the pathogenesis of fatty liver and disease progression to steatohepatitis: implications for treatment. Carter-Kent C; Zein NN; Feldstein AE Am J Gastroenterol; 2008 Apr; 103(4):1036-42. PubMed ID: 18177455 [TBL] [Abstract][Full Text] [Related]